The use of ENAR therapy in Australia - A phase IV post-market surveillance study
Bonello, R. (2015) The use of ENAR therapy in Australia - A phase IV post-market surveillance study. Journal of the Australian Traditional-Medicine Society, 21 (2). pp. 100-104.
Objective: To report the effectiveness and safety of the ENAR device as well as the conditions for which the therapy was employed and its perceived effectiveness. The impact of therapy on medication use is also explored.
Design and setting: An Australian post-market, web-based survey of ENAR therapy users.
Results: Most respondents (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder and neck pain; 8% used ENAR exclusively for non-musculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% [t(423) = 38.73, p< .001] and functional improvement of 62% [t(423) = 10.45, p< .001] using 11-point numerical rating scales. Following ENAR treatment medication reduction was reported by 91% of respondents. Very few respondents reported safety incidents or concerns with the therapy.
Conclusions: Most respondents reported high satisfaction and a reduction in medication use following ENAR therapy, with between 15-20% reporting complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction.
|Publication Type:||Journal Article|
|Murdoch Affiliation:||School of Health Professions|
|Publisher:||Australian Traditional-Medicine Society|
|Item Control Page|